With new data, a biotech tries to relieve doubts about the durability of its gene therapy for Fabry disease

Submitted by admin on February 6, 2019 - 9:40am

Source:

Stat

News Tags:

Avrobio

Fabry disease

Headline:

With new data, a biotech tries to relieve doubts about the durability of its gene therapy for Fabry disease

snippet:

An experimental gene therapy developed by the small biotech Avrobio (AVRO) reduced a type of fat that builds up to toxic levels in the cells and organs of patients with Fabry disease, the company reported Wednesday.

Search form

You are here

With new data, a biotech tries to relieve doubts about the durability of its gene therapy for Fabry disease

With new data, a biotech tries to relieve doubts about the durability of its gene therapy for Fabry disease